IMARA
Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia. IMR-687 is being designed to have a multimodal mechanism of action that acts on red blood cells, white blood cells, adhesion mediators and other cell types.
IMARA
Industry:
Biopharma Biotechnology Genetics Health Care Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.imaratx.com
Total Employee:
11+
Status:
Active
Contact:
617 231-6021
Email Addresses:
[email protected]
Total Funding:
144.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics WordPress Google Universal Analytics Font Awesome Apache
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Adendra Therapeutics
Adendra Therapeutics wants to use new insights into dendritic cell biology to develop a novel type of immunotherapy.
Alector
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
Apostle
Apostle Inc is a provider of innovative technologies and services for public health and life sciences.
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
Biochip Labs
Biochip Labs provides blood disorder testing for conditions like sickle cell disease and thalassemia.
Biognosys
Biognosys provides the best possible solutions to support researchers in their protein analysis needs.
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Cleave Therapeutics
Cleave Therapeutics is focused on protein homeostasis and stress pathways in cancer and neurodegeneration.
Cystetic Medicines
Cystetic Medicines develops a treatment that potentially could help people with cystic fibrosis (CF), regardless of genetic mutation.
Kinnate Biopharma
Kinnate Biopharma develops precision oncology therapeutics to treat patients with genomically-defined cancers.
LiVeritas Biosciences
Committed to Truth-telling for Early Success in Drug Development
Loxo Oncology
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
MiaDNA
MiaDNA provides people with the genetic information they need to improve their lifestyle and living habits.
NanoMosaic
NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.
Nimbus Therapeutics
Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company.
NonExomics
NonExomics develops therapeutics to diagnose and cure diseases emanating from the nonexome.
OncoResponse
OncoResponse is a company providing cancer research into immunotherapies and the newest technologies for oncologists.
QUE Oncology
QUE Oncology develops novel therapies to address unmet medical needs in the treatment of cancer and its consequences.
Refuge Biotechnologies
Refuge Biotechnologies therapeutic company focused on gene editing and genetic engineering of immune cells for cancer immunotherapy.
REGENXBIO
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
Swing Therapeutics
Swing Therapeutics provides digital therapeutics for people with chronic conditions.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Rock Springs Capital
Rock Springs Capital investment in Series B - Imara
Bay City Capital
Bay City Capital investment in Series B - Imara
OrbiMed
OrbiMed investment in Series B - Imara
RA Capital Management
RA Capital Management investment in Series B - Imara
Arix Bioscience
Arix Bioscience investment in Series B - Imara
New Enterprise Associates
New Enterprise Associates investment in Series B - Imara
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - Imara
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series B - Imara
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - Imara
Bay City Capital
Bay City Capital investment in Series A - Imara
Official Site Inspections
http://www.imaratx.com Semrush global rank: 4.29 M Semrush visits lastest month: 2.68 K
- Host name: 172.67.143.45
- IP address: 172.67.143.45
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
